HCA Healthcare, Inc. (NYSE:HCA) Shares Bought by LGT Fund Management Co Ltd.

Key Points

• LGT Fund Management Co Ltd. has increased its stake in HCA Healthcare by 4.4%, bringing its total holdings to 27,352 shares valued at approximately $9.45 million.
• The company has reported a quarterly EPS of $6.84, exceeding analysts' expectations, with revenue reaching $18.61 billion, a 6.4% increase year-over-year.
• HCA Healthcare will pay a quarterly dividend of $0.72 per share on September 30th, representing an annualized yield of 0.8% and a payout ratio of 12.11%.

LGT Fund Management Co Ltd. grew its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 4.4% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 27,352 shares of the company's stock after purchasing an additional 1,153 shares during the period. LGT Fund Management Co Ltd.'s holdings in HCA Healthcare were worth $9,451,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. Cheviot Value Management LLC bought a new position in HCA Healthcare during the first quarter valued at about $26,000. Atwood & Palmer Inc. bought a new position in HCA Healthcare during the first quarter valued at about $28,000. Bartlett & CO. Wealth Management LLC boosted its stake in HCA Healthcare by 888.9% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company's stock valued at $31,000 after buying an additional 80 shares in the last quarter. ORG Partners LLC boosted its position in shares of HCA Healthcare by 344.0% in the 1st quarter. ORG Partners LLC now owns 111 shares of the company's stock valued at $38,000 after purchasing an additional 86 shares during the period. Finally, Migdal Insurance & Financial Holdings Ltd. boosted its position in shares of HCA Healthcare by 75.8% in the 1st quarter. Migdal Insurance & Financial Holdings Ltd. now owns 116 shares of the company's stock valued at $40,000 after purchasing an additional 50 shares during the period. Institutional investors own 62.73% of the company's stock.

Analyst Ratings Changes

HCA has been the subject of a number of recent analyst reports. Baird R W lowered HCA Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 15th. JPMorgan Chase & Co. raised their price objective on HCA Healthcare from $360.00 to $370.00 and gave the stock a "neutral" rating in a research report on Monday, August 4th. Wells Fargo & Company raised HCA Healthcare from an "underweight" rating to an "equal weight" rating and raised their price target for the stock from $320.00 to $385.00 in a research note on Thursday, May 29th. Stephens raised HCA Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. Finally, Royal Bank Of Canada cut their price target on HCA Healthcare from $404.00 to $401.00 and set an "outperform" rating for the company in a research note on Monday, July 28th. Nine analysts have rated the stock with a hold rating, nine have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $395.69.

HCA Healthcare Stock Up 0.3%

Shares of HCA stock opened at $382.90 on Tuesday. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $417.14. The firm has a market cap of $89.60 billion, a PE ratio of 16.10, a price-to-earnings-growth ratio of 1.20 and a beta of 1.39. The stock has a 50 day moving average of $369.76 and a 200-day moving average of $350.02. The company has a quick ratio of 0.86, a current ratio of 0.98 and a debt-to-equity ratio of 69.07.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings results on Friday, July 25th. The company reported $6.84 EPS for the quarter, topping analysts' consensus estimates of $6.20 by $0.64. The company had revenue of $18.61 billion during the quarter, compared to analyst estimates of $18.49 billion. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%. The company's quarterly revenue was up 6.4% compared to the same quarter last year. During the same period in the previous year, the company earned $5.50 earnings per share. On average, equities analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th will be given a dividend of $0.72 per share. The ex-dividend date is Tuesday, September 16th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.8%. HCA Healthcare's payout ratio is currently 12.11%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.